| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |